CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 119 filers reported holding CHEMOCENTRYX INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,520,000 | +2300.0% | 106,862 | +332.6% | 0.01% | +700.0% |
| Q2 2019 | $230,000 | -94.9% | 24,700 | -92.4% | 0.00% | -90.9% |
| Q1 2019 | $4,511,000 | +88.0% | 324,748 | +47.6% | 0.01% | +83.3% |
| Q4 2018 | $2,400,000 | -9.9% | 220,004 | +4.4% | 0.01% | 0.0% |
| Q3 2018 | $2,664,000 | +111.8% | 210,762 | +120.7% | 0.01% | +100.0% |
| Q2 2018 | $1,258,000 | +170.5% | 95,494 | +179.1% | 0.00% | +200.0% |
| Q1 2018 | $465,000 | +200.0% | 34,216 | +31.5% | 0.00% | – |
| Q4 2017 | $155,000 | +15.7% | 26,016 | +44.5% | 0.00% | – |
| Q3 2017 | $134,000 | – | 17,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 436,300 | $15,886,000 | 6.25% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,205,000 | 3.66% |
| Integral Health Asset Management, LLC | 200,000 | $7,282,000 | 2.02% |
| Sofinnova Investments, Inc. | 731,222 | $26,624,000 | 1.56% |
| Lisanti Capital Growth, LLC | 231,035 | $8,412,000 | 1.22% |
| Darwin Global Management, Ltd. | 161,802 | $5,891,000 | 0.90% |
| Cormorant Asset Management, LP | 400,000 | $14,564,000 | 0.87% |
| Perceptive Advisors | 2,830,892 | $103,072,000 | 0.80% |
| Avidity Partners Management LP | 644,400 | $23,463,000 | 0.50% |
| Eventide Asset Management | 1,040,000 | $37,866,000 | 0.48% |